CMO, Hematology of Beigene, Ltd. (NASDAQ:BGNE), Huang Jane, sells 3,000 shares worth $629,787

According to Beigene, Ltd.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jul 31 04:24 PM, company CMO, Hematology, Huang Jane disclosed selling 3,000 shares at a cost of $209.93. At the time of this transaction (Jul 29), this trade was worth $629,787 in total. As of Jul 29, Huang Jane now owns 0 shares in total worth about $0.0.

For the last few recent trades made by Beigene, Ltd. (NASDAQ:BGNE) CMO, Hematology, Huang Jane, we have the following information:

  1. SEC Form 4 filing: Jul 07: Sold 3,921 shares at the rate of $200.00 per share. Total worth of this trade was $784,200. Total number of shares owned as of Jul 07 were 0
  2. SEC Form 4 filing: Jun 26: Sold 2,079 shares at the rate of $200.29 per share. Total worth of this trade was $416,397. Total number of shares owned as of Jun 26 were 0
  3. SEC Form 4 filing: Jun 29: Sold 1,935 shares at the rate of $190.83 per share. Total worth of this trade was $369,250. Total number of shares owned as of Jun 29 were 0
Posted by on Friday July 31 2020, 5:54 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments closed, Trackbacks open. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in